Influence of streptozotocin diabetes on myocardial lipids and prostaglandin release by the rat heart.
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism*; D015232:Dinoprostone; D011464:Epoprostenol / Q000378:metabolism; D050356:Lipid Metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D011453:Prostaglandins / Q000378:metabolism*; D011458:Prostaglandins E / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013311:Streptozocin
D001095:Arachidonic Acids; D011453:Prostaglandins; D011458:Prostaglandins E; D015121:6-Ketoprostaglandin F1 alpha; D013311:Streptozocin; D011464:Epoprostenol; D015232:Dinoprostone